| Literature DB >> 32668009 |
Wei Zhen Yeh1,2, Melissa Gresle1,2, Vilija Jokubaitis1,2, Jim Stankovich1, Anneke van der Walt1,2, Helmut Butzkueven1,2.
Abstract
Initially recognised as an important factor for bone health, vitamin D is now known to have a range of effects on the immune system. Vitamin D deficiency is associated with an increased risk of multiple sclerosis (MS), a chronic immune-mediated demyelinating disease of the CNS. In this review, we explore the links between vitamin D deficiency, MS risk, and disease activity. We also discuss the known immune effects of vitamin D supplementation and the relevance of these observations to the immunopathology of MS. Finally, we review the existing evidence for vitamin D supplementation as an MS therapy, highlighting several recent clinical studies and trials.Entities:
Keywords: cholecalciferol; genetic; immune; multiple sclerosis; supplementation; therapeutic; transcriptome; treatment; vitamin D
Mesh:
Substances:
Year: 2020 PMID: 32668009 PMCID: PMC7443468 DOI: 10.1111/bph.15201
Source DB: PubMed Journal: Br J Pharmacol ISSN: 0007-1188 Impact factor: 8.739